The course of depressive symptoms in predicting relapse in schizophrenia: A double-blind, randomized comparison of olanzapine and risperidone

Biological Psychiatry

Volumn 46, Issue 3, 1999, Pages 365-373

  Tollefson, Gary D ^a   Andersen, Scott W ^a   Tran, Pierre V ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Depression; Mood; Olanzapine; Relapse; Risperidone; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; MOOD; MULTICENTER STUDY; NEGATIVE SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RELAPSE; RISK ASSESSMENT; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLUSTER ANALYSIS; COGNITION DISORDERS; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PIRENZEPINE; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; REGRESSION ANALYSIS; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0032769624     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00049-9     Document Type: Article

References (31)

1. Arnt J., Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology. 18:1998;63-101.
2. Birchwood M., Mason R., Macmillan F., Healy J. Depression, demoralization and control over psychotic illness a comparison of depressed and non-depressed patients with a chronic psychosis . Psychol Med. 23:1993;387-395.
3. Birchwood M., Smith J., MacMillan F., Hogg B., Prasad R., Harvey C., et al. Predicting relapse in schizophrenia the development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation . Psychol Med. 19:1989;649-656.
4. Doering S., Muller E., Kopcke W., Pietzcker A., Gaebel W., Linden M., et al. Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder. Schizophr Bull. 24:1998;87-98.
5. Dwight M.M., Keck P.E., Stanton S.P., Strakowski S.M., McElroy S.L. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet. 344:1994;554-555.
6. Geddes J., Mercer G., Frith C.D., McMillan F., Owens D.G., Johnstone E.C. Prediction of outcome following a first-episode of schizophrenia a follow-up study of Northwick Park first episode study subjects . Br J Psychiatry. 165:1994;664-668.
7. Guy W. ECDEU Assessment Manual for Psychopharmacology. 1976;U.S. Department of Health, Education, and Welfare, Bethesda, MD.
8. Herz M., Melville C. Relapse in schizophrenia. Am J Psychiatry. 137:1980;801-812.
9. Hosmer D., Lemeshow S. Applied Logistic Regression. 1989;Wiley, New York.
10. Janowsky D.S., Overstreet D.H. The role of acetylcholine mechanisms in mood disorders. Bloom F.E., Kupfer D.J. Psychopharmacology The Fourth Generation of Progress . 1995;945-956 Raven Press, New York.
11. Jonsson H., Nyman A.K. Predicting long-term outcome in schizophrenia. Acta Psychiatr Scand. 83:1991;342-346.
12. Jorgensen P. Early signs of psychotic relapse in schizophrenia. Br J Psychiatry. 172:1998;327-330.
13. Kay S.R., Opler L.A., Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Manual. 1986;Multi-Health Systems, Inc, North Tonawanda, NY.
14. Kay S.R., Sevy S. Pyramidal model of schizophrenia. Schizophr Bull. 16:1990;537-545.
15. Koreen A.R., Siris S.G., Chakos M., Alvir J., Mayerhoff D., Lieberman J. Depression in first-episode schizophrenia. Am J Psychiatry. 150:1993;1643-1648.
16. Malla A.K., Norman R.M.G. Prodromal symptoms in schizophrenia a prospective investigation . Br J Psychiatry. 164:1994;487-493.
17. McGlashan T.H. A selective review of recent North American follow-up studies of schizophrenia. Schizophr Bull. 14:1988;515-542.
18. McGlashan T.H., Carpenter W.T. Jr. An investigation of the post psychotic depressive syndrome. Am J Psychiatry. 133:1976;14-19.
19. Möller H.J., von Zerssen D. The course and outcome of schizophrenia. Hirsch S.R., Weinberger D.R. Schizophrenia. 1995;106-127 Blackwell Science, Oxford, England.
20. Prentice R.L., Zhao L.P. Estimating equations for parameters in means and covariances of multivariate discrete and continuous responses. Biometrics. 47:1991;825-839.
21. Roy A., Thompson R., Kennedy S. Depression in chronic schizophrenia. Br J Psychiatry. 142:1983;465-470.
22. SAS Institute (1989): SAS/STAT User's Guide, Version 6, 4th ed, vols 1 and 2. Cary, NC: SAS Institute.
23. Siris S.G. Depression and schizophrenia. Hirsch S.R., Weinberger D.R. Schizophrenia. 1995;128-145 Blackwell Science, Oxford, England.
24. Tohen M, Sanger TM, Tollefson GD, McElroy SL, Greaney MG, Toma V (June 1998): Olanzapine versus placebo in the treatment of acute mania. NCDEU 38th Annual Meeting, Boca Raton, FL.
25. Tollefson G.D., Andersen S.W. Should we consider mood disturbance in schizophrenia as an important determinant of quality-of-life? J Clin Psychiatry. 60:(Suppl 5):1999;23-29.
26. Tollefson G.D., Beasley C.M. Jr, Tran P.V., Street J.S., Krueger J.A., Tamura R.N., et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders results of an international collaborative trial . Am J Psychiatry. 154:1997;457-465.
27. Tollefson G.D., Sanger T.M., Beasley C.M. A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia. Biol Psychiatry. 43:1998;803-810.
28. Tollefson G.D., Sanger T.M., Lu Y., Thieme M.E. Depressive signs and symptoms in schizophrenia. A prospective blinded trial of olanzapine and haloperidol. Arch Gen Psychiatry. 55:1998;250-258.
29. Tran P.V., Hamilton S.H., Kuntz A.J., Potvin J.H., Andersen S.W., Beasley C.M. Jr, et al. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol. 17:1997;407-418.
30. Vaillant G.E. Prospective prediction of schizophrenic remission. Arch Gen Psychiatry. 11:1964;509-518.
31. Yung A.R.E., McGorry P.D. The prodromal phase of first-episode psychosis past and current conceptualizations . Schizophr Bull. 22:1996;353-370.